Blue Companion
BLUE COMPANION provides digital services for health through private-public partnership projects. They also offer CRO services by designing and conducting clinical studies, as well as providing project management and study management services. Their privileged therapeutic domains are neurodegenerative and neuromuscular diseases, as well as ophthalmology.
BLUECompanion also designs, deploys and manages customised integrated ICT platforms to treat and monitor on quasi real time different data sources (auto-evaluation questionnaires, wearable devices, robotic interfaces, mobile phones…).
Learn more: www.bluecompanion.eu
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
May 27, 2025
24 June 2025 Join our upcoming webinar in collaboration with PharmaLex to explore current challenges in clinical trials for targeted therapies. We’ll discuss how eClinical solutions can optimize processes—from managing complex data to coordinating stakeholders and enabling real-time decision-making. This interactive session is designed for industry professionals at the intersection of technology and clinical research. […]
May 27, 2025
28 May 2025 – 04:00 PM to 05:00 PM CET (Webinar) Yoanni Th. Matsakis, President of Telemedicine Technologies, attends the first xShare webinar on the EHDS Adoption Kit for citizens. The event introduces the European Health Data Space (EHDS) and the European Electronic Health Record Exchange Format (EEHRxF). It explores data-driven healthcare through “The Health […]
May 27, 2025
Med City News Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient’s history. A panel discussed these applications and more during MedCity News’s INVEST conference in Chicago. In the life sciences community, there’s a […]